Guidelines for development and implementation of biocatalytic P450 processes

Applied Microbiology and Biotechnology

Volumn 99, Issue 6, 2015, Pages 2465-2483

  Lundemo, Marie T ^a   Woodley, John M ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

Biocatalysis; Bioprocess engineering; P450 monooxygenases; Whole cell biotransformation

Indexed keywords

BIOCATALYSTS; BIOCHEMICAL ENGINEERING; CELLS; CYTOLOGY; ENZYMES; FUNCTIONAL GROUPS;

BIOCATALYSIS; BIOCATALYTIC REACTION; BIOLOGICAL CHARACTERISTIC; BIOPROCESS ENGINEERING; CYTOCHROME P450 MONOOXYGENASES; MONOOXYGENASES; PHARMACEUTICAL RESEARCH; WHOLE-CELL BIOTRANSFORMATIONS;

CELL ENGINEERING;

CYTOCHROME P450; OXYGEN;

BACTERIAL CELL; BIOCATALYST; CATALYSIS; CELL ENGINEERING; CELL MEMBRANE; ECONOMIC ASPECT; ELECTRON TRANSPORT; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; FUNGAL CELL; HOST SELECTION; HUMAN; HYDROXYLATION; MEMBRANE TRANSPORT; NONHUMAN; OXYGEN CONSUMPTION; PRACTICE GUIDELINE; PROCESS DEVELOPMENT; PROTEIN EXPRESSION; REVIEW; SOLUBILITY; TOXICITY; WHOLE CELL; BIOCATALYSIS; BIOREACTOR; ENZYME SPECIFICITY; FERMENTATION; METABOLISM; PROTEIN ENGINEERING;

BIOCATALYSIS; BIOREACTORS; CYTOCHROME P-450 ENZYME SYSTEM; FERMENTATION; HYDROXYLATION; PROTEIN ENGINEERING; SUBSTRATE SPECIFICITY;

EID: 84925535983     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-015-6403-x     Document Type: Review

References (131)

1. Ajikumar PK, Xiao W, Tyo KEJ, Wang Y, Simeon F, Leonard E, Mucha O, Phon TH, Pfeifer B, Stephanopoulos G (2010) Isoprenoid pathway optimization for taxol precursor overproduction in Escherichia coli. Science (Washington, DC, U S) 330:70–74
2. Armstrong FH, Fisher KC (1947) The oxygen consumption associated with growth in Escherichia coli and the effect of sulfathiazole and of n-propyl carbamate on it. J Gen Physiol 30:279–289
3. Baldwin CVF, Woodley JM (2006) On oxygen limitation in a whole cell biocatalytic Baeyer–Villiger oxidation process. Biotechnol Bioeng 95:362–369
4. Bell SG, McMillan JH, Yorke JA, Kavanagh E, Johnson EO, Wong L (2012) Tailoring an alien ferredoxin to support native-like P450 monooxygenase activity. Chem Commun 48:11692–11694
5. Bernhardt R, Urlacher VB (2014) Cytochromes P450 as promising catalysts for biotechnological application: chances and limitations. Appl Microbiol Biotechnol 98:6185–6203
6. Blank LM, Ebert BE, Bühler B, Schmid A (2008) Metabolic capacity estimation of Escherichia coli as a platform for redox biocatalysis: constraint‐based modeling and experimental verification. Biotechnol Bioeng 100:1050–1065
7. Bleif S, Hannemann F, Zapp J, Hartmann D, Jauch J, Bernhardt R (2012) A new Bacillus megaterium whole-cell catalyst for the hydroxylation of the pentacyclic triterpene 11-keto-β-boswellic acid (KBA) based on a recombinant cytochrome P450 system. Appl Microbiol Biotechnol 93:1135–1146
8. Bordeaux M, Galarneau A, Fajula F, Drone J (2011) A regioselective biocatalyst for alkane activation under mild conditions. Angew Chem Int Ed 123:2123–2127
9. Bornscheuer U, Huisman G, Kazlauskas R, Lutz S, Moore J, Robins K (2012) Engineering the third wave of biocatalysis. Nature 485:185–194
10. Braun A, Geier M, Bühler B, Schmid A, Mauersberger S, Glieder A (2012) Steroid biotransformations in biphasic systems with Yarrowia lipolytica expressing human liver cytochrome P450 genes. Microb Cell Fact 11:106–121
11. Bühler B, Schmid A (2004) Process implementation aspects for biocatalytic hydrocarbon oxyfunctionalization. J Biotechnol 113:183–210
12. Bühler B, Straathof AJJ, Witholt B, Schmid A (2006) Analysis of two-liquid-phase multistep biooxidation based on a process model: indications for biological energy shortage. Org Process Res Dev 10:628–643
13. Bühler B, Park JB, Blank LM, Schmid A (2008) NADH availability limits asymmetric biocatalytic epoxidation in a growing recombinant Escherichia coli strain. Appl Environ Microbiol 74:1436–1446
14. Chefson A, Zhao J, Auclair K (2006) Replacement of natural cofactors by selected hydrogen peroxide donors or organic peroxides results in improved activity for CYP3A4 and CYP2D6. Chembiochem 7:916–919
15. Chen RR (2007) Permeability issues in whole-cell bioprocesses and cellular membrane engineering. Appl Microbiol Biotechnol 74:730–738
16. Cirino PC, Arnold FH (2003) A self‐sufficient peroxide‐driven hydroxylation biocatalyst. Angew Chem Int Ed 115:3421–3423
17. Cirino PC, Arnold FH (2008) Polymorphic monooxygenase comprising mutation in heme domain of a secondary structural element and enhanced heat stability; improved peroxide-driven hydroxylation. US7465567 B2
18. Cornelissen S, Liu S, Deshmukh AT, Schmid A, Bühler B (2011) Cell physiology rather than enzyme kinetics can determine the efficiency of cytochrome P450-catalyzed C–H-oxyfunctionalization. J Ind Microbiol Biotechnol 38:1359–1370
19. Cornelissen S, Julsing MK, Volmer J, Riechert O, Schmid A, Bühler B (2013) Whole‐cell‐based CYP153A6‐catalyzed (S)‐limonene hydroxylation efficiency depends on host background and profits from monoterpene uptake via AlkL. Biotechnol Bioeng 110:1282–1292
20. Cote P, Bersillon JL, Huyard A, Faup G (1988) Bubble-free aeration using membranes: process analysis. J Water Pollut Control Fed 60:1986–1992
21. Dafoe JT, Daugulis AJ (2014) In situ product removal in fermentation systems: improved process performance and rational extractant selection. Biotechnol Lett 36:443–460
22. De Montellano PRO (2005) Cytochrome P450: structure, mechanism, and biochemistry. Plenum, New York
23. Drăgan CA, Peters FT, Bour P, Schwaninger AE, Schaan SM, Neunzig I, Widjaja M, Zapp J, Kraemer T, Maurer HH (2011) Convenient gram-scale metabolite synthesis by engineered fission yeast strains expressing functional human P450 systems. Appl Biochem Biotechnol 163:965–980
24. Duetz WA, Van Beilen JB, Witholt B (2001) Using proteins in their natural environment: potential and limitations of microbial whole-cell hydroxylations in applied biocatalysis. Curr Opin Biotechnol 12:419–425
25. Duport C, Spagnoli R, Degryse E, Pompon D (1998) Self-sufficient biosynthesis of pregnenolone and progesterone in engineered yeast. Nat Biotechnol 16:186–189
26. Eiben S, Kaysser L, Maurer S, Kühnel K, Urlacher VB, Schmid RD (2006) Preparative use of isolated CYP102 monooxygenases—a critical appraisal. J Biotechnol 124:662–669
27. Eiben S, Bartelmäs H, Urlacher VB (2007) Construction of a thermostable cytochrome P450 chimera derived from self-sufficient mesophilic parents. Appl Microbiol Biotechnol 75:1055–1061
28. Ewen KM, Ringle M, Bernhardt R (2012) Adrenodoxin—a versatile ferredoxin. IUBMB Life 64:506–512
29. Fasan R, Chen MM, Crook NC, Arnold FH (2007) Engineered alkane‐hydroxylating cytochrome P450BM3 exhibiting nativelike catalytic properties. Angew Chem Int Ed 119:8566–8570
30. Fasan R, Crook NC, Peters MW, Meinhold P, Buelter T, Landwehr M, Cirino PC, Arnold FH (2011) Improved product‐per‐glucose yields in P450‐dependent propane biotransformations using engineered Escherichia coli. Biotechnol Bioeng 108:500–510
31. Favre-Bulle O, Witholt B (1992) Biooxidation of n-octane by a recombinant Escherichia coli in a two-liquid-phase system: effect of medium components on cell growth and alkane oxidation activity. Enzyme Microb Technol 14:931–937
32. Fujii T, Fujii Y, Machida K, Ochiai A, Ito M (2009) Efficient biotransformations using Escherichia coli with tolC acrAB mutations expressing cytochrome P450 genes. Biosci Biotechnol Biochem 73:805–810
33. Furuya T, Arai Y, Kino K (2012) Biotechnological production of caffeic acid by bacterial cytochrome P450 CYP199A2. Appl Environ Microbiol 78:6087–6094
34. Gillam EMJ, Hayes MA (2013) The evolution of cytochrome P450 enzymes as biocatalysts in drug discovery and development. Curr Top Med Chem 13:2254–2280
35. Grant C, Woodley JM, Baganz F (2011) Whole-cell bio-oxidation of n-dodecane using the alkane hydroxylase system of P. putida GPo1 expressed in E. coli. Enzyme Microb Technol 48:480–486
36. Grogan G (2011) Cytochromes P450: exploiting diversity and enabling application as biocatalysts. Curr Opin Chem Biol 15:241–248
37. Guengerich FP, Munro AW (2013) Unusual cytochrome p450 enzymes and reactions. J Biol Chem 288:17065–17073
38. Hakki T, Zearo S, Dragan C, Bureik M, Bernhardt R (2008) Coexpression of redox partners increases the hydrocortisone (cortisol) production efficiency in CYP11B1 expressing fission yeast Schizosaccharomyces pombe. J Biotechnol 133:351–359
39. Hannemann F, Bichet A, Ewen KM, Bernhardt R (2007) Cytochrome P450 systems—biological variations of electron transport chains. BBA-Gen Subjects 1770:330–344
40. Hilker I, Alphand V, Wohlgemuth R, Furstoss R (2004) Microbial transformations, 56. Preparative scale asymmetric Baeyer–Villiger oxidation using a highly productive “Two‐in‐One” resin‐based in situ SFPR concept. Adv Synth Catal 346:203–214
41. Hirakawa H, Nagamune T (2010) Molecular assembly of P450 with ferredoxin and ferredoxin reductase by fusion to PCNA. ChemBioChem 11:1517–1520
42. Hlavica P (2009) Assembly of non-natural electron transfer conduits in the cytochrome P450 system: a critical assessment and update of artificial redox constructs amenable to exploitation in biotechnological areas. Biotechnol Adv 27:103–121
43. Hollmann F, Hofstetter K, Schmid A (2006) Non-enzymatic regeneration of nicotinamide and flavin cofactors for monooxygenase catalysis. Trends Biotechnol 24:163–171
44. Joo H, Lin Z, Arnold FH (1999) Laboratory evolution of peroxide-mediated cytochrome P450 hydroxylation. Nature (London) 399:670–673
45. Julsing MK, Cornelissen S, Bühler B, Schmid A (2008) Heme-iron oxygenases: powerful industrial biocatalysts? Curr Opin Chem Biol 12:177–186
46. Julsing MK, Schrewe M, Cornelissen S, Hermann I, Schmid A, Bühler B (2012) Outer membrane protein AlkL boosts biocatalytic oxyfunctionalization of hydrophobic substrates in Escherichia coli. Appl Environ Microbiol 78:5724–5733
47. Jung ST, Lauchli R, Arnold FH (2011) Cytochrome P450: taming a wild type enzyme. Curr Opin Biotechnol 22:809–817
48. Kim D, Ortiz de Montellano PR (2009) Tricistronic overexpression of cytochrome P450 cam, putidaredoxin, and putidaredoxin reductase provides a useful cell-based catalytic system. Biotechnol Lett 31:1427–1431
49. Kleser M, Hannemann F, Hutter M, Zapp J, Bernhardt R (2012) CYP105A1 mediated 3-hydroxylation of glimepiride and glibenclamide using a recombinant Bacillus megaterium whole-cell catalyst. J Biotechnol 157:405–412
50. Kolar NW, Swart AC, Mason JI, Swart P (2007) Functional expression and characterisation of human cytochrome P45017α in Pichia pastoris. J Biotechnol 129:635–644
51. Kuhn D, Bühler B, Schmid A (2012) Production host selection for asymmetric styrene epoxidation: Escherichia coli vs. solvent-tolerant Pseudomonas. J Ind Microbiol Biotechnol 39:1125–1133
52. Laane C, Boeren S, Vos K, Veeger C (1987) Rules for optimization of biocatalysis in organic solvents. Biotechnol Bioeng 30:81–87
53. Labinger JA (2004) Selective alkane oxidation: hot and cold approaches to a hot problem. J Mol Catal A Chem 220:27–35
54. Lamb SB, Lamb DC, Kelly SL, Stuckey DC (1998) Cytochrome P450 immobilisation as a route to bioremediation/biocatalysis. FEBS Lett 431:343–346
55. Lee W, Kim M, Jin Y, Seo J (2013) Engineering of NADPH regenerators in Escherichia coli for enhanced biotransformation. Appl Microbiol Biotechnol 97:2761–2772
56. Lewis JC, Arnold FH (2009) Catalysts on demand: selective oxidations by laboratory-evolved cytochrome P450 BM3. CHIMIA Int J Chem 63:309–312
57. Liese A, Seelbach K, Wandrey C (2006) Industrial biotransformations. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany
58. Lima-Ramos J, Tufvesson P, Woodley JM (2014) Application of environmental and economic metrics to guide the development of biocatalytic processes. Green Proc Synth 3:195–213
59. Lin Y, Lu P, Tang C, Mei Q, Sandig G, Rodrigues AD, Rushmore TH, Shou M (2001) Substrate inhibition kinetics for cytochrome P450-catalyzed reactions. Drug Metab Dispos 29:368–374
60. Liu Y, Kondo A, Ohkawa H, Shiota N, Fukuda H (1998) Bioconversion using immobilized recombinant flocculent yeast cells carrying a fused enzyme gene in an ‘intelligent’ bioreactor. Biochem Eng J 2:229–235
61. Liu S, Li C, Fang X, Cao Z (2004) Optimal pH control strategy for high-level production of long-chain α, ω-dicarboxylic acid by Candida tropicalis. Enzyme Microb Technol 34:73–77
62. Lye GJ, Woodley JM (1999) Application of in situ product-removal techniques to biocatalytic processes. Trends Biotechnol 17:395–402
63. Lynch RM, Woodley JM, Lilly MD (1997) Process design for the oxidation of fluorobenzene to fluorocatechol by Pseudomonas putida. J Biotechnol 58:167–175
64. Ma SK, Gruber J, Davis C, Newman L, Gray D, Wang A, Grate J, Huisman GW, Sheldon RA (2010) A green-by-design biocatalytic process for atorvastatin intermediate. Green Chem 12:81–86
65. Malca S (2012) Bacterial CYP153A monooxygenases for the synthesis of omega-hydroxylated fatty acids. Chem Commun 48:5115–5117
66. Martinez CA, Rupashinghe SG (2013) Cytochrome P450 bioreactors in the pharmaceutical industry: challenges and opportunities. Curr Top Med Chem 13:1470–1490
67. Maurer SC, Schulze H, Schmid RD, Urlacher V (2003) Immobilisation of P450 BM‐3 and an NADP cofactor recycling system: towards a technical application of heme‐containing monooxygenases in fine chemical synthesis. Adv Synth Catal 345:802–810
68. Maurer SC, Kühnel K, Kaysser LA, Eiben S, Schmid RD, Urlacher VB (2005) Catalytic hydroxylation in biphasic systems using CYP102A1 mutants. Adv Synth Catal 347:1090–1098
69. McIntosh JA, Farwell CC, Arnold FH (2014) Expanding P450 catalytic reaction space through evolution and engineering. Curr Opin Chem Biol 19:126–134
70. Meyer D, Buehler B, Schmid A (2006) Process and catalyst design objectives for specific redox biocatalysis. Adv Appl Microbiol 59:53–91
71. Michener JK, Nielsen J, Smolke CD (2012) Identification and treatment of heme depletion attributed to overexpression of a lineage of evolved P450 monooxygenases. Proc Natl Acad Sci U S A 109:19504–19509
72. Mouri T, Michizoe J, Ichinose H, Kamiya N, Goto M (2006) A recombinant Escherichia coli whole cell biocatalyst harboring a cytochrome P450cam monooxygenase system coupled with enzymatic cofactor regeneration. Appl Microbiol Biotechnol 72:514–520
73. Munro AW, Girvan HM, McLean KJ (2007a) Variations on a (t) heme—novel mechanisms, redox partners and catalytic functions in the cytochrome P450 superfamily. Nat Prod Rep 24:585–609
74. Munro AW, Girvan HM, McLean KJ (2007b) Cytochrome P450—redox partner fusion enzymes. BBA-Gen Subjects 1770:345–359
75. Nelson DR (2009) The cytochrome P450 homepage. Hum Genomics 4:59–65
76. Nthangeni M, Urban P, Pompon D, Smit M, Nicaud J (2004) The use of Yarrowia lipolytica for the expression of human cytochrome P450 CYP1A1. Yeast 21:583–592
77. O’Reilly E, Köhler V, Flitsch SL, Turner NJ (2011) Cytochromes P450 as useful biocatalysts: addressing the limitations. Chem Commun 47:2490–2501
78. Oudshoorn A, van den Berg C, Roelands C, Straathof A, Van der Wielen L (2010) Short-cut calculations for integrated product recovery options in fermentative production of bio-bulk chemicals. Process Biochem 45:1605–1615
79. Paddon C, Westfall P, Pitera D, Benjamin K, Fisher K, McPhee D, Leavell M, Tai A, Main A, Eng D (2013) High-level semi-synthetic production of the potent antimalarial artemisinin. Nature 496:528–532
80. Panke S, Wubbolts MG, Schmid A, Witholt B (2000) Production of enantiopure styrene oxide by recombinant Escherichia coli synthesizing a two‐component styrene monooxygenase. Biotechnol Bioeng 69:91–100
81. Panke S, Held M, Wubbolts MG, Witholt B, Schmid A (2002) Pilot‐scale production of (S)‐styrene oxide from styrene by recombinant Escherichia coli synthesizing styrene monooxygenase. Biotechnol Bioeng 80:33–41
82. Park JW, Lee JK, Kwon TJ, Yi DH, Kim YJ, Moon SH, Suh HH, Kang SM, Park YI (2003) Bioconversion of compactin into pravastatin by Streptomyces sp. Biotechnol Lett 25:1827–1831
83. Pflug S, Richter SM, Urlacher VB (2007) Development of a fed-batch process for the production of the cytochrome P450 monooxygenase CYP102A1 from Bacillus megaterium in E. coli. J Biotechnol 129:481–488
84. Ramos JL, Duque E, Gallegos MT, Godoy P, Ramos-González MI, Rojas A, Terán W, Segura A (2002) Mechanisms of solvent tolerance in Gram-negative bacteria. Annu Rev Microbiol 56:743–768
85. Rendic S, Guengerich FP (2010) Update information on drug metabolism systems—2009, part II. Summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters. Curr Drug Metab 11:4–84
86. Richardson TH, Jung F, Griffin KJ, Wester M, Raucy JL, Kemper B, Bornheim LM, Hassett C, Omiecinski CJ, Johnson EF (1995) A universal approach to the expression of human and rabbit cytochrome P450s of the 2C subfamily in Escherichia coli. Arch Biochem Biophys 323:87–96
87. Robin A, Roberts GA, Kisch J, Sabbadin F, Grogan G, Bruce N, Turner NJ, Flitsch SL (2009) Engineering and improvement of the efficiency of a chimeric [P450cam-RhFRed reductase domain] enzyme. Chem Comm:2478–2480
88. Ryan JD, Clark DS (2008) P450cam biocatalysis in surfactant‐stabilized two‐phase emulsions. Biotechnol Bioeng 99:1311–1319
89. Sadeghi SJ, Gilardi G (2013) Chimeric P450 enzymes: activity of artificial redox fusions driven by different reductases for biotechnological applications. Biotechnol Appl Biochem 60:102–110
90. Salazar O, Cirino PC, Arnold FH (2003) Thermostabilization of a cytochrome P450 peroxygenase. Chem Biochem 4:891–893
91. Savile CK, Janey JM, Mundorff EC, Moore JC, Tam S, Jarvis WR, Colbeck JC, Krebber A, Fleitz FJ, Brands J, Devine PN, Huisman GW, Hughes GJ (2010) Biocatalytic asymmetric synthesis of chiral amines from ketones applied to sitagliptin manufacture. Science 329:305–309
92. Scheer M, Grote A, Chang A, Schomburg I, Munaretto C, Rother M, Söhngen C, Stelzer M, Thiele J, Schomburg D (2011) BRENDA, the enzyme information system in 2011. Nucleic Acids Res 39:D670–D676
93. Scheps D, Honda Malca S, Richter SM, Marisch K, Nestl BM, Hauer B (2013) Synthesis of ω-hydroxy dodecanoic acid based on an engineered CYP153A fusion construct. Microb Biotechnol 6:694–707
94. Schewe H, Kaup BA, Schrader J (2008) Improvement of P450 BM-3 whole-cell biocatalysis by integrating heterologous cofactor regeneration combining glucose facilitator and dehydrogenase in E. coli. Appl Microbiol Biotechnol 78:55–65
95. Schewe H, Holtmann D, Schrader J (2009) P450 BM-3-catalyzed whole-cell biotransformation of α-pinene with recombinant Escherichia coli in an aqueous–organic two-phase system. Appl Microbiol Biotechnol 83:849–857
96. Schmid A, Kollmer A, Mathys RG, Witholt B (1998a) Developments toward large-scale bacterial bioprocesses in the presence of bulk amounts of organic solvents. Extremophiles 2:249–256
97. Schmid A, Sonnleitner B, Witholt B (1998b) Medium chain length alkane solvent‐cell transfer rates in two‐liquid phase, Pseudomonas oleovorans cultures. Biotechnol Bioeng 60:10–23
98. Schneider S, Wubbolts MG, Sanglard D, Witholt B (1998) Biocatalyst engineering by assembly of fatty acid transport and oxidation activities for in vivo application of cytochrome P-450BM-3 monooxygenase. Appl Environ Microbiol 64:3784–3790
99. Schrewe M, Julsing MK, Bühler B, Schmid A (2013) Whole-cell biocatalysis for selective and productive C–O functional group introduction and modification. Chem Soc Rev 42:6346–6377
100. Schulz S, Girhard M, Urlacher VB (2012) Biocatalysis: key to selective oxidations. ChemCatChem 4:1889–1895
101. Schumacher SD, Jose J (2012) Expression of active human P450 3A4 on the cell surface of Escherichia coli by Autodisplay. J Biotechnol 161:113–120
102. Schumacher SD, Hannemann F, Teese MG, Bernhardt R, Jose J (2012) Autodisplay of functional CYP106A2 in Escherichia coli. J Biotechnol 161:104–112
103. Schwaneberg U, Appel D, Schmitt J, Schmid RD (2000) P450 in biotechnology: zinc driven ω-hydroxylation of p-nitrophenoxydodecanoic acid using P450 BM-3 F87A as a catalyst. J Biotechnol 84:249–257
104. Seifert A, Antonovici M, Hauer B, Pleiss J (2011) An efficient route to selective bio-oxidation catalysts: an iterative approach comprising modeling, diversification, and screening, based on CYP102A1. ChemBioChem 12:1346–1351
105. Seng Wong T, Arnold FH, Schwaneberg U (2004) Laboratory evolution of cytochrome P450 BM‐3 monooxygenase for organic cosolvents. Biotechnol Bioeng 85:351–358
106. Shet MS, Fisher CW, Estabrook RW (1997) The function of recombinant cytochrome P450s in intact Escherichia coli cells: the 17α-hydroxylation of progesterone and pregnenolone by P450c17. Arch Biochem Biophys 339:218–225
107. Shimizu M, Lilly MD, Woodley JM (2003) Regiospecific naphthalene monohydroxylation by a recombinant yeast producing a P4501A1–yeast reductase fused enzyme. Enzyme Microb Technol 33:606–611
108. Siriphongphaew A, Pisnupong P, Wongkongkatep J, Inprakhon P, Vangnai AS, Honda K, Ohtake H, Kato J, Ogawa J, Shimizu S (2012) Development of a whole-cell biocatalyst co-expressing P450 monooxygenase and glucose dehydrogenase for synthesis of epoxyhexane. Appl Microbiol Biotechnol 95:357–367
109. Sono M, Roach MP, Coulter ED, Dawson JH (1996) Heme-containing oxygenases. Chem Rev 96:2841–2888
110. Staijen IE, van Beilen JB, Witholt B (2000) Expression, stability and performance of the three‐component alkane mono‐oxygenase of Pseudomonas oleovorans in Escherichia coli. Eur J Biochem 267:1957–1965
111. Straathof AJJ, Panke S, Schmid A (2002) The production of fine chemicals by biotransformations. Curr Opin Biotechnol 13:548–556
112. Szczebara FM, Chandelier C, Villeret C, Masurel A, Bourot S, Duport C, Blanchard S, Groisillier A, Testet E, Costaglioli P (2003) Total biosynthesis of hydrocortisone from a simple carbon source in yeast. Nat Biotechnol 21:143–149
113. Taylor M, Lamb DC, Cannell RJP, Dawson MJ, Kelly SL (2000) Cofactor recycling with immobilized heterologous cytochrome P450 105D1 (CYP105D1). Biochem Biophys Res Commun 279:708–711
114. Tran N, Nguyen D, Dwaraknath S, Mahadevan S, Chavez G, Nguyen A, Dao T, Mullen S, Nguyen T, Cheruzel LE (2013) An efficient light-driven P450 BM3 biocatalyst. J Am Chem Soc 135:14484–14487
115. Tufvesson P, Lima-Ramos J, Nordblad M, Woodley JM (2011) Guidelines and cost analysis for catalyst production in biocatalytic processes. Org Process Res Dev 15:266–274
116. Urlacher VB, Girhard M (2012) Cytochrome P450 monooxygenases: an update on perspectives for synthetic application. Trends Biotechnol 30:26–36
117. Vail RB, Homann MJ, Hanna I, Zaks A (2005) Preparative synthesis of drug metabolites using human cytochrome P450s 3A4, 2C9 and 1A2 with NADPH-P450 reductase expressed in Escherichia coli. J Ind Microbiol Biotechnol 32:67–74
118. Van Dien S (2013) From the first drop to the first truckload: commercialization of microbial processes for renewable chemicals. Curr Opin Biotechnol 24:1061–1068
119. Walton AZ, Stewart JD (2002) An efficient enzymatic Baeyer–Villiger oxidation by engineered escherichia coli cells under Non-growing conditions. Biotechnol Prog 18:262–268
120. Walton AZ, Stewart JD (2004) Understanding and improving NADPH‐dependent reactions by nongrowing Escherichia coli cells. Biotechnol Prog 20:403–411
121. Weber E, Sirim D, Schreiber T, Thomas B, Pleiss J, Hunger M, Gläser R, Urlacher VB (2010) Immobilization of P450 BM-3 monooxygenase on mesoporous molecular sieves with different pore diameters. J Mol Catal B 64:29–37
122. Whitehouse CJ, Bell SG, Wong L (2012) P450BM3 (CYP102A1): connecting the dots. Chem Soc Rev 41:1218–1260
123. Wohlgemuth R (2010) Biocatalysis—key to sustainable industrial chemistry. Curr Opin Biotechnol 21:713–724
124. Wohlgemuth R, Woodley JM (2010) Asymmetric Baeyer–Villiger reactions using whole-cell biocatalysts. Asymmetric Catal Ind Scale (2nd Ed):230–248
125. Woodley J (2006) Choice of biocatalyst form for scalable processes. Biochem Soc Trans 34:301–303
126. Woodley JM (2008) New opportunities for biocatalysis: making pharmaceutical processes greener. Trends Biotechnol 26:321–327
127. Woodley JM, Bisschops M, Straathof AJJ, Ottens M (2008) Future directions for in-situ product removal (ISPR). J Chem Technol Biotechnol 83:121–123
128. Zehentgruber D, Hannemann F, Bleif S, Bernhardt R, Lütz S (2010a) Towards preparative scale steroid hydroxylation with cytochrome P450 monooxygenase CYP106A2. ChemBioChem 11:713–721
129. Zehentgruber D, Drǎgan C, Bureik M, Lütz S (2010b) Challenges of steroid biotransformation with human cytochrome P450 monooxygenase CYP21 using resting cells of recombinant Schizosaccharomyces pombe. J Biotechnol 146:179–185
130. Zhang W, O’Connor K, Wang DI, Li Z (2009) Bioreduction with efficient recycling of NADPH by coupled permeabilized microorganisms. Appl Environ Microbiol 75:687–694
131. Zhang J, Li A, Xu J (2010) Improved expression of recombinant cytochrome P450 monooxygenase in Escherichia coli for asymmetric oxidation of sulfides. Bioprocess Biosyst Eng 33:1043–1049